Next-Gen Biosafety Masterclass

Next Generation Sequencing (NGS) in Biosafety Testing: From Regulation to Routine Use

SEPTEMBER 10, 2026 in Paris (France)

PathoQuest is pleased to announce the upcoming Next-Gen Biosafety Masterclass: "Next Generation Sequencing (NGS) in Biosafety Testing: From Regulation to Routine Use."

🗓️ September 10, 2026

🕣 Registration: 08:30–09:00 CEST
🗣️ Presentations: 09:00–17:15 CEST
🍸 Cocktail Reception: 17:15–18:15 CEST

📍 11 Rue Watt, BioPark, Bâtiment B, 75013 Paris, France

👤 IN-PERSON

A full day of expert insights — explore the agenda below:

  • Welcome & Strategic Context
    Colette Côté – Chief Scientific & Portfolio Officer, PathoQuest
    Horst Ruppach – Executive Director Scientific and Portfolio, Global Biologics, Charles River Laboratories
  • Biologics: Market Trends, Pipeline Dynamics, and Industrial Production
    Elsa Kress – Head of Business Development, MabDesign
  • European Regulations on detection of viral adventitious agents by next generation sequencing
    Johannes Bluemel – Head of Viral Safety Section, Paul-Ehrlich-Institut
  • Global overview of implementation and regulatory acceptance of NGS for vaccines safety testing
    Laura Viviani – Founder and consultant at SciEthiQ
  • NGS in Viral Safety: From Comparison of Methods to Qualification
    Florence Suavet – Chief Technical Officer, PathoQuest
    Marc Eloit – Founder & Scientific Advisor, PathoQuest
  • Characterization of starting materials for the production of Virus Therapeutics by Next Generation Sequencing (NGS)
    Michael Ruffing – Global Development CMC Biologicals, Boehringer Ingelheim
  • Integrated Use of Viromic and Transcriptomic NGS for Adventitious Virus Testing
    Jens Modrof – Director Operations, Global Pathogen Safety, Takeda
  • Agency Expectations and the Use of NGS: Have They Finally Aligned?
    Colette Côté – Chief Scientific & Portfolio Officer, PathoQuest
    Horst Ruppach – Executive Director Scientific and Portfolio, Global Biologics, Charles River Laboratories
  • The Power and Challenges of NGS in Viral Vector Identity Assays
    Nadia Avenier – Head of Analytical Expertise Center, Yposkesi / an SK pharmteco company
  • Industry Speaker Title TBC
    Carine Logvinoff – Virology Global Analytical Expert, Sanofi
  • Adoption of NGS for Viral Safety Testing in Exosome Manufacturing
    Huilan Lin – Principal Scientist, Capricor Therapeutics
  • Ask the Experts – Interactive Session
    All speakers
  • Closing Remarks & Networking Cocktail
    Colette Côté – Chief Scientific & Portfolio Officer, PathoQuest

    • 👉 Free registration is now open.

    Seating is limited. Secure your place today.

REGISTER NOW FOR FREE